Acute dysphonia secondary to vocal fold hemorrhage after vardenafil use

May 31, 2010 by Vikas Singh, MD, Seth M. Cohen, MD, MPH, Bernard Rousseau, PhD, J. Pieter Noordzij, MD, C. Gaelyn Garrett, MD, and Robert H. Ossoff, DMD, MD
| Reprints

Abstract

Owing to their vasodilatory effects, the phosphodiesterase-5 inhibitors have become widely used for the treatment of erectile dysfunction. Among the reported adverse events of these agents are epistaxis, variceal bleeding, intracranial hemorrhage, and hemorrhoidal bleeding. We report a case of vocal fold hemorrhage that occurred after vardenafil use in a 31-year-old man who was a professional singer.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

REGISTER AS A MEMBER: http://www.entjournal.com/user/register

SIGN IN: http://www.entjournal.com/user